LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 61

Search options

  1. Article ; Online: Can China's 'standard of care' for COVID-19 be replicated in Europe?

    Raposo, Vera Lucia

    Journal of medical ethics

    2020  Volume 46, Issue 7, Page(s) 451–454

    Abstract: The Director-General of the WHO has suggested that China's approach to the COVID-19 crisis could be the standard of care for global epidemics. However, as remarkable as the Chinese strategy might be, it cannot be replicated in other countries and ... ...

    Abstract The Director-General of the WHO has suggested that China's approach to the COVID-19 crisis could be the standard of care for global epidemics. However, as remarkable as the Chinese strategy might be, it cannot be replicated in other countries and certainly not in Europe. In Europe, there is a distribution of power between the European Union and its member states. In contrast, China's political power is concentrated in the central government. This enables it to take immediate measures that affect the entire country, such as massive quarantines or closing borders. Moreover, the Chinese legal framework includes restrictions on privacy and other human rights that are unknown in Europe. In addition, China has the technological power to easily impose such restrictions. In most European countries, that would be science fiction. These conditions have enabled China to combat epidemics like no other country can. However, the WHO might have been overoptimistic. The Chinese standard of care for treating COVID-19 also raises problematic issues for human rights, and the real consequences of these actions remain to be seen.
    MeSH term(s) Betacoronavirus ; COVID-19 ; China/epidemiology ; Coronavirus Infections/epidemiology ; Europe/epidemiology ; Human Rights/ethics ; Human Rights/standards ; Humans ; Pandemics ; Pneumonia, Viral/epidemiology ; Privacy ; SARS-CoV-2 ; Standard of Care/ethics ; Standard of Care/standards
    Keywords covid19
    Language English
    Publishing date 2020-05-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 194927-5
    ISSN 1473-4257 ; 0306-6800
    ISSN (online) 1473-4257
    ISSN 0306-6800
    DOI 10.1136/medethics-2020-106210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The First Chinese Edited Babies: A Leap of Faith in Science.

    Raposo, Vera Lucia

    JBRA assisted reproduction

    2019  Volume 23, Issue 3, Page(s) 197–199

    MeSH term(s) CRISPR-Cas Systems/genetics ; China ; Cloning, Organism/ethics ; Cloning, Organism/methods ; Cloning, Organism/trends ; Embryo Research/ethics ; Ethics, Research ; Female ; Gene Editing/ethics ; Gene Editing/methods ; Gene Editing/trends ; Genetic Enhancement/ethics ; Genetic Enhancement/methods ; Genetic Predisposition to Disease ; HIV Infections/genetics ; Humans ; Infant, Newborn ; Pregnancy ; Receptors, CCR5/genetics ; Reproductive Techniques, Assisted/ethics ; Reproductive Techniques, Assisted/trends
    Chemical Substances CCR5 protein, human ; Receptors, CCR5
    Language English
    Publishing date 2019-08-22
    Publishing country Brazil
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2856226-4
    ISSN 1518-0557 ; 1517-5693
    ISSN (online) 1518-0557
    ISSN 1517-5693
    DOI 10.5935/1518-0557.20190042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: From Public Eugenics to Private Eugenics: What Does the Future Hold?

    Raposo, Vera Lúcia

    JBRA assisted reproduction

    2022  Volume 26, Issue 4, Page(s) 666–674

    Abstract: Traditional public eugenics, which was ordered by the State, has been replaced by a kind of private eugenics conducted by parents using reproductive techniques, genetic testing and, eventually in the future, genetic engineering. While traditional ... ...

    Abstract Traditional public eugenics, which was ordered by the State, has been replaced by a kind of private eugenics conducted by parents using reproductive techniques, genetic testing and, eventually in the future, genetic engineering. While traditional eugenics strived to improve the species, the new model aims to satisfy parents' reproductive aspirations. The association between public and private eugenics is an ongoing issue, mostly due to its relation to nazi eugenics. This paper will state that both are eugenics; however, with different characteristics, and thus worthy of different legal and ethical assessments. The paper will contextualize private eugenics in the framework of reproductive rights (legal and ethical perspective) and in the development of genetics and reproductive techniques (scientific perspective). Finally, it will analyze some of the legal consequences of a broader acceptance of private eugenics, namely in terms of liability and tort law. Throughout the paper, the different legal solutions in place in Europe will contextualize its considerations.
    MeSH term(s) Humans ; Eugenics ; Genetic Testing ; Reproduction
    Language English
    Publishing date 2022-11-09
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 2856226-4
    ISSN 1518-0557 ; 1517-5693
    ISSN (online) 1518-0557
    ISSN 1517-5693
    DOI 10.5935/1518-0557.20220032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A Room with a View (and with a Gene Therapy Drug): Gene Therapy Medicinal Products and Genetic Tourism in Europe.

    Raposo, Vera Lúcia

    European journal of health law

    2022  Volume 29, Issue 3-5, Page(s) 504–520

    Abstract: In contrast to the extreme caution that has been imposed on genetic medical procedures, in European law genetic drugs, or medications, have found a legal loophole that allows flexible (perhaps too flexible) access to these drugs. In Europe, Gene Therapy ... ...

    Abstract In contrast to the extreme caution that has been imposed on genetic medical procedures, in European law genetic drugs, or medications, have found a legal loophole that allows flexible (perhaps too flexible) access to these drugs. In Europe, Gene Therapy Medicinal Products are a form of Advanced Therapy Medicinal Products and as such submitted to the marketing authorization procedure. However, there are legal mechanisms in place - such as compassionate use, named patient use, and hospital exception - that allow for their provision to patients without proper approval. This is not, de per se, problematic; the problem arises, though, because such mechanisms are neither properly regulated nor monitored, and their application differs substantially according to the jurisdiction. This disparity and lack of control have given rise to situations of genetic tourism, where patients in desperate need travel to so-called genetic paradises, looking for a miraculous, and extremely expensive cure. The outcome is sometimes tragic, endangering patients' safety and undermining confidence in genetic products.
    MeSH term(s) Humans ; Tourism ; Europe ; Patient Safety ; Genetic Therapy
    Language English
    Publishing date 2022-04-08
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1195903-4
    ISSN 1571-8093 ; 0929-0273
    ISSN (online) 1571-8093
    ISSN 0929-0273
    DOI 10.1163/15718093-bja10083
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: The Use of Facial Recognition Technology by Law Enforcement in Europe: a Non-Orwellian Draft Proposal.

    Raposo, Vera Lúcia

    European journal on criminal policy and research

    2022  , Page(s) 1–19

    Abstract: The European legal framework is not devoid of norms that are directly or indirectly applicable to facial recognition technology for identification purposes within law enforcement. However, these various norms, which have different targets and are from ... ...

    Abstract The European legal framework is not devoid of norms that are directly or indirectly applicable to facial recognition technology for identification purposes within law enforcement. However, these various norms, which have different targets and are from multiple sources, create a kind of legal patchwork that could undermine the lawful use of this technology in criminal investigations. This paper advocates the creation of a specific law on the use of facial recognition technology for identification in law enforcement, based on existing regulations, to specifically address the pressing issues arising in this domain. The ultimate aim is to allow its use under certain conditions and to protect the rights of the people involved, but also to provide law enforcement authorities with the necessary tools to combat serious crimes.
    Language English
    Publishing date 2022-06-01
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2015435-5
    ISSN 1572-9869 ; 0928-1371
    ISSN (online) 1572-9869
    ISSN 0928-1371
    DOI 10.1007/s10610-022-09512-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Macau, a luta contra a Covid-19 no olho do furação

    Vera Lucia Raposo

    Cadernos Ibero-americanos de Direito Sanitário, Vol 9, Iss 2, Pp 12-

    2020  Volume 28

    Abstract: Objectivo: analisar como a Região Administrativa Especial de Macau lida com a pandemia causada pelo novo coronavírus, SARS-CoV-2. Metodologia: análise das leis vigentes no território, das decisões tomadas e das práticas adoptadas. Resultados: Macau, ... ...

    Abstract Objectivo: analisar como a Região Administrativa Especial de Macau lida com a pandemia causada pelo novo coronavírus, SARS-CoV-2. Metodologia: análise das leis vigentes no território, das decisões tomadas e das práticas adoptadas. Resultados: Macau, diferentemente de vários outros países, já possuía legislação específica de combate a crises sanitárias – Lei nº 2/2004 – o que facilitou a adopção de medidas restritivas de direitos e liberdades de forma imediata, e sem indagações quanto à sua legalidade e/ou constitucionalidade. O comportamento social da população e a adopção de medidas voluntárias – uso de máscaras e quarentena voluntária – também foram identificados como factores importantes para enfrentar a doença. Os princípios da precaução e da necessidade podem ser claramente observados na adopção das medidas de saúde pelo governo de Macau. Conclusão: o controlo da pandemia foi conseguido por via de várias medidas – umas de base legal, outras puramente sociais –, que contaram com o apoio da população. Macau é um autêntico case study de como se controla uma pandemia.
    Keywords covid-19. pandemias. macau ; Medical legislation ; K3601-3611 ; covid19
    Language Spanish
    Publishing date 2020-08-01T00:00:00Z
    Publisher Fundação Oswaldo Cruz (FIOCRUZ)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Pigs Don't Fly and You Cannot Expect Absolutely Safe COVID-19 Vaccines (But You Should Expect a Fair Compensation).

    Raposo, Vera Lúcia

    European journal of health law

    2021  Volume 28, Issue 2, Page(s) 165–183

    Abstract: This paper focuses on the COVID-19 vaccines authorised for use in the European Union, and explores the mechanisms in place to control vaccine safety and to compensate injured patients, mainly in the context of European law. Based on these considerations, ...

    Abstract This paper focuses on the COVID-19 vaccines authorised for use in the European Union, and explores the mechanisms in place to control vaccine safety and to compensate injured patients, mainly in the context of European law. Based on these considerations, the paper concludes that the refusal by some potential vaccinees to take the vaccine based on safety concerns is ungrounded and an indication of unrealistic expectations, but that in order to build public trust proper compensation mechanisms should be in place.
    MeSH term(s) COVID-19/prevention & control ; COVID-19 Vaccines ; Compensation and Redress/legislation & jurisprudence ; Drug Approval ; European Union ; Humans ; Patient Safety ; SARS-CoV-2/immunology
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-04-19
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1195903-4
    ISSN 1571-8093 ; 0929-0273
    ISSN (online) 1571-8093
    ISSN 0929-0273
    DOI 10.1163/15718093-BJA10042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: What to Do in the Next Pandemic Outbreak: Natural Herd Immunity Versus Lockdown (Lessons Learned from COVID-19).

    Raposo, Vera Lúcia

    Journal of law and medicine

    2021  Volume 29, Issue 1, Page(s) 260–269

    Abstract: The purpose of this article is to analyse non-pharmaceutical approaches to control pandemics. Currently vaccines are our best hope to control the COVID-19 pandemic, but before the appearance of the first vaccines the available possibilities were much ... ...

    Abstract The purpose of this article is to analyse non-pharmaceutical approaches to control pandemics. Currently vaccines are our best hope to control the COVID-19 pandemic, but before the appearance of the first vaccines the available possibilities were much more limited. While most people worldwide were confined to their homes to slow the spread of the new coronavirus, some countries (most notably the United Kingdom) advocated infecting the majority of the community, aiming to achieve what has been called "herd immunity". This article focuses on two non-therapeutic strategies for dealing with deadly viruses and points out their respective problems: natural herd immunity and quarantines/lockdowns. It analyses these strategies from three perspectives: legal, ethical and social. The article concludes that in the absence of therapeutic alternatives (vaccines), short-term lockdowns are necessary, but long-term lockdowns are legally, ethically, socially and financially impossible to sustain.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; Communicable Disease Control ; Disease Outbreaks/prevention & control ; Humans ; Immunity, Herd ; Influenza Vaccines/therapeutic use ; Influenza, Human/epidemiology ; Influenza, Human/prevention & control ; Pandemics/prevention & control
    Chemical Substances Influenza Vaccines
    Language English
    Publishing date 2021-12-16
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 1236328-5
    ISSN 1320-159X
    ISSN 1320-159X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The new Japanese regulation on human/non-human chimeras: should we worry?

    Raposo, Vera Lúcia

    JBRA assisted reproduction

    2021  Volume 25, Issue 1, Page(s) 155–161

    Abstract: In March 2019 Japan modified its norms regarding research with human/non-human chimeras. The amended rules allow the creation of chimeras with human brain cells, and the subsequent transfer of the resulting creature to an uterus, where it can develop for ...

    Abstract In March 2019 Japan modified its norms regarding research with human/non-human chimeras. The amended rules allow the creation of chimeras with human brain cells, and the subsequent transfer of the resulting creature to an uterus, where it can develop for more than 14 days, eventually until term. At this moment, the real consequences of this new regulation in actual research are still uncertain. However, many concerning issues have already been identified. This paper will start by addressing traditional topics involving this practice: the use of non-human animals in research, the use of human stem cells in scientific experimentation and the creation of human/non-human chimeras. Subsequently, it will analyze the new concerning issues brought on by the 2019 amendment: the use of human brain cells, the transfer of the chimera to an uterus and its development for more than 14 days, and the possibility of using animals which present close similarities with humans. In the end, the paper will conclude that in spite of the legal and ethical hazards that this new regulation might carry, it should be allowed under strict scrutiny.
    MeSH term(s) Animals ; Chimera ; Female ; Humans ; Japan
    Language English
    Publishing date 2021-02-02
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 2856226-4
    ISSN 1518-0557 ; 1517-5693
    ISSN (online) 1518-0557
    ISSN 1517-5693
    DOI 10.5935/1518-0557.20200045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top